A New York-based biotech company is turning heads on Tuesday after it announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense’s...

To read the full story on AllPennyStocks.com, click here.

Seelos Therapeutics (NASDAQ:SEEL)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025 Haga Click aquí para más Gráficas Seelos Therapeutics.
Seelos Therapeutics (NASDAQ:SEEL)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025 Haga Click aquí para más Gráficas Seelos Therapeutics.